Clements, Thomas W.
Ball, Chad G.
Nicol, Andrew J.
Edu, Sorin
Kirkpatrick, Andrew W.
Navsaria, Pradeep
Article History
Received: 29 January 2022
Accepted: 4 June 2022
First Online: 20 June 2022
Declarations
:
: Ethics review for this study was provided by the institutional review board of the University of Cape Town.
: Not applicable.
: AW Kirkpatrick has consulted for the Zoll, Acelity (3M/KCI), CSL Behring, Innovative Trauma Care and SAM Medical Corporations, and the Statesman Group of Companies, and is the PI of a randomized trial partially supported by the Acelity Corporation.